quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:17:35·9h
INSIDERFiling
Belite Bio Inc logo

Chief Financial Officer Chuang Hao-Yuan acquired 10,000 units of Ordinary Share, increasing direct ownership by 5% to 205,264 units (SEC Form 4)

BLTE· Belite Bio Inc
Health Care
Original source

Companies

  • BLTE
    Belite Bio Inc
    Health Care

Recent analyst ratings

  • Jan 26UpdateBofA Securities$195.00
  • Jan 6UpdateMorgan Stanley$191.00
  • Dec 2UpdateMizuho$194.00
  • Nov 24UpdateCantor Fitzgerald$154.00
  • Nov 20UpdateMizuho$105.00
  • Dec 14UpdateMaxim Group$60.00

Related

  • INSIDER9h
    Chief Executive Officer Lin Yu-Hsin acquired 10,000 units of Ordinary Share, increasing direct ownership by 6% to 182,949 units (SEC Form 4)
  • INSIDER9h
    SEC Form 4 filed by Chief Medical Officer Scholl Hendrik Peter
  • INSIDER9h
    Chief Scientific Officer Mata Nathan L. sold $170,384 worth of American depositary share (1,000 units at $170.38) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 10,666 units (SEC Form 4)
  • PR17h
    International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on April 28, 2026
  • PR18h
    Belite Bio to Participate in Four Upcoming Investor Conferences
  • INSIDER1d
    SEC Form 4 filed by Mata Nathan L.
  • PR1d
    Belite Bio to Present at the Deutsche Bank American Depositary Receipt Virtual Investor Conference on April 28th
  • INSIDER2d
    SEC Form 4 filed by Mata Nathan L.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022